Effects of angiotensin-converting enzyme inhibitor and angiotensin Ⅱ receptor blocker on one-year outcomes of patients with atrial fibrillation:insights from a multicenter registry study in China

Si-Qi LYU; Yan-Min YANG; Jun ZHU; Juan WANG; Shuang WU; Jia-Meng REN; Han ZHANG; Xing-Hui SHAO

doi:10.11909/j.issn.1671-5411.2020.12.005

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Effects of angiotensin-converting enzyme inhibitor and angiotensin Ⅱ receptor blocker on one-year outcomes of patients with atrial fibrillation:insights from a multicenter registry study in China

DOI: 10.11909/j.issn.1671-5411.2020.12.005

Effects of angiotensin-converting enzyme inhibitor and angiotensin Ⅱ receptor blocker on one-year outcomes of patients with atrial fibrillation:insights from a multicenter registry study in China

Si-Qi LYU

Yan-Min YANG

Jun ZHU

Juan WANG

Shuang WU

Jia-Meng REN

Han ZHANG

Xing-Hui SHAO

Keywords：Angiotensin-converting enzyme inhibitorAngiotensin Ⅱ receptor blockerAtrial fibrillationMortality

Publication Date：2020-12-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：9( 750-758 )

Journal of Geriatric Cardiology

SCICSCD

ISSN：1671-5411

Year, Vol.(Issue)：2020,17(12)